BCL2 and non-small cell lung carcinoma: Furthermore, combined treatment with harmine and Bcl-2 antagonist significantly suppressed primary NSCLC cell colony formation when compared to treatment with single agents (Figure 6B, combination therapy vs. monotherapy, P < 0.05).